Skip to main content
    N

    Nyxoah (NYXH)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.89
    -0.01 (-0.64%)

    Market Cap: $91.61M

    Last updated: Nov 17, 2026 at 10:51 AM ET

    Earnings

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-0.22
    Range-0.25 - -0.19
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-0.26+16.7%
    60d ago-0.21-5.0%
    30d ago-0.21-5.0%
    7d ago-0.21-6.0%
    Current-0.22
    Revenue Consensus
    12.81M
    Range11.36M - 14.60M
    4 analysts
    Last 12 of 31 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    Date TBD
    --0.22-0.25 - -0.19--2
    1
    0
    30d
    -
    Dec 26EST
    Date TBD
    -N/AN/A-----
    Sep 26
    Reported Nov 5
    -0.20-0.24-0.54 - -0.21--4
    0
    1
    30d
    -
    Jun 26
    Reported Aug 5
    -0.67-0.47-0.49 - -0.26--5
    1
    0
    30d
    -
    Mar 26
    Reported May 12
    -0.43-0.63N/A--5
    3
    0
    30d
    -
    Dec 25
    Reported Mar 19
    -0.59-0.55-0.66 - -0.40--5
    0
    1
    30d
    -
    Sep 25
    Reported Nov 13
    -0.63-0.56-0.70 - -0.54--4
    1
    3
    30d
    -
    Jun 25
    Reported Aug 18
    -0.63-0.62-0.65 - -0.51--5
    2
    3
    30d
    -
    Mar 25
    Reported May 14
    -0.60-0.51-0.57 - -0.40--5
    0
    2
    30d
    -
    Dec 24
    Reported Mar 13
    -0.46-0.44-0.56 - -0.33--5
    2
    1
    30d
    -
    Sep 24
    Reported Nov 6
    -0.50-0.45-0.54 - -0.39--5
    1
    1
    30d
    -
    Jun 24
    Reported Aug 6
    -0.43-0.41-0.48 - -0.32--5
    No revisions (30d)
    -
    Mar 24
    Reported May 14
    -0.41-0.41-0.49 - -0.39--5
    1
    0
    30d
    -
    Dec 23
    Reported Mar 5
    -0.38-0.37-0.53 - -0.25--5
    No revisions (30d)
    -

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-1.05xFCF Yield-95.34%
    Profitability
    Profit Margin0.00%Operating Margin-282.50%
    ROE-151.80%ROIC-65.86%
    Financial Health
    Debt/Equity0.67xInterest Coverage-3.57x
    Current Ratio2.19xQuick Ratio2.08x
    Trading Statistics
    Beta1.02Avg Volume270.82K
    52-Week High$5.3952-Week Low$0.80

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 24.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 37.5, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.88
    SMA 20$0.88
    SMA 50$1.19
    SMA 200$2.28
    EMA 10$0.89
    EMA 20$0.94
    EMA 50$1.14
    EMA 200$2.28

    MACD

    Line: -0.08Signal: -0.11Hist: 0.02

    ADX

    ADX: 27.7+DI: 19.0-DI: 30.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down36.0
    PSAR$0.81

    Bollinger Bands

    Upper Band$0.94
    Lower Band$0.81
    %B Position1459%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    37.5

    Momentum Oscillators

    Stoch %K55.1
    Stoch %D55.9
    Williams %R-46.3
    ROC (10d)1.5%
    Momentum0.01
    CCI (20d)26.3
    MFI (14d)61.7

    Volatility Measures

    ATR (14d)$0.06(6.4%)
    StdDev (20d)0.03
    Hist Vol55.7%(High)

    Volume Flow

    VWAP$0.89
    OBV-5.5M
    AD Line-12.2M
    CMF (20d)-0.169

    Volume Metrics

    Avg Vol (20d)260.1K
    Vol Ratio0.2x(Low)
    VWMA (20d)$0.88

    Pivot Points

    R3$0.93
    R2$0.92
    R1$0.91
    Pivot Point$0.89
    S1$0.88
    S2$0.87
    S3$0.86

    Advanced Oscillators

    TSI-32.55
    Ultimate Osc62.3
    KST-263.14

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about NYXH

    News

    NYXH Valuation

    GNG's valuation label for NYXH is Undervalued.

    P/FCF
    -1.0x
    P/B
    1.2x
    All NYXH metrics

    NYXH Profitability: Margins, ROIC and FCF

    Nyxoah (NYXH) has a gross margin of 54.3%, an operating margin of -282.5% and a net margin of 0.0%. It posts -65.9% ROIC.

    Gross margin
    54.3%
    Operating margin
    -282.5%
    Net margin
    0.0%
    ROIC
    -65.9%
    ROE
    -151.8%
    FCF yield
    -95.3%
    NYXH financial statements

    The companies most similar to Nyxoah (NYXH) include Owlet, MaxCyte and Inogen.

    Sector: Healthcare

    Companies most similar to Nyxoah

    NYXH Analyst Ratings

    Nyxoah (NYXH) has a Hold consensus from 4 analysts: 2 Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell.

    Consensus
    Hold
    Analysts
    4
    Strong Buy
    0
    Buy
    2
    Hold
    2
    Sell
    0
    Strong Sell
    0

    NYXH Bull Case vs Bear Case

    Bull case

    • NYXH grew quarterly revenue 365.0% year over year.

    NYXH Earnings Call

    The latest NYXH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About NYXH

    Does NYXH pay dividends?

    Nyxoah (NYXH) does not currently pay a regular dividend.

    What is NYXH's market cap?

    Nyxoah (NYXH) has a market capitalization of $91.61M with a current stock price of $0.89.

    How do analysts rate NYXH stock?

    4 analysts cover Nyxoah (NYXH): 0 rate it Strong Buy, 2 Buy, 2 Hold, 0 Sell and 0 Strong Sell, a consensus of Hold.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.